Skip to main content
. 2018 Apr 19;17(6):8091–8100. doi: 10.3892/mmr.2018.8895

Table I.

Compared with adjacent non-tumorous tissues, 227 DEGs were identified from the datasets analyzed, 82 of which were upregulated genes and 145 which were downregulated genes in breast cancer tissues.

DEGs Genes
Upregulated DLGAP5, APOBEC3B, RAD51AP1, ASPN, BIRC5, LMNB1, NDC80, BGN, KIF4A, GINS1, RACGAP1, IFI6, EZH2, KIF20A, CMPK2, CCNB1, UHRF1, SQLE, VCAN, UBE2C, PTTG1, PPAPDC1A, BUB1, COL5A2, TYMS, RSAD2, FNDC1, DTL, CCNE2, BUB1B, ECT2, CXCR4, UBE2T, CDKN3, ADAMDEC1, PBK, LYZ, MELK, FAM83D, POSTN, STAT1, CXCL9, ZWINT, CEP55, PRR11, HMMR, PRC1, CEACAM6, CKS2, CDK1, CCNB2, TPX2, MMP9, COL1A2, ANLN, CENPU, MAD2L1, ISG15, CENPF, COL1A1, NEK2, CXCL11, SULF1, MMP1, GJB2, FN1, MMP11, ASPM, SPP1, INHBA, COMP, KIAA0101, WISP1, LRRC15, TOP2A, NUSAP1, RRM2, S100P, CTHRC1, CXCL10, COL10A1, COL11A1
Downregulated ADH1B, KRT14, C2orf40, DST, SFRP1, CD36, PI15, SYNM, NTRK2, ZBTB16, ABCA8, MAMDC2, OXTR, FABP4, MUCL1, PDK4, TGFBR3, KRT15, WIF1, FOSB, CFD KRT5, CHRDL1, FMO2, GPC3, APOD, ADAMTS5, PLIN1, MAOA, SCGB3A1, ID4, AK5, FHL1, CD300LG, THRSP, CLDN11, CAV1, SORBS1, LAMA3, SCARA5, FAM189A2, MIR143HG, PIGR, ACKR1, GHR, ATP1A2, RBP4, PDLIM3, CCL28, CHL1, FOS, STEAP4, BTNL9, AKR1C1, ADIPOQ, EGFR, MYBPC1, IGFBP6, ITM2A, OGN, GPX3, NOVA1, PGR, HBB, EGR1, MYH11, TF, LIFR, CXCL12, KIT, ACACB, CXCL14, SYNPO2, DMD, TFPI2, KLHL13, SRPX, SEMA3G, LEP, ENPP2, HOXA5, AKR1C3, RHOJ, ACTG2, SDPR, MIR205HG, ANXA3, LPL, ATF3, KLF4, PAMR1, TMTC1, SEMA6D, CRYAB MEOX1, HLF, ANPEP, LYVE1, ADIRF, WLS, SOCS2, ALDH1A1, AQP1, PLIN4, SPRY2, THRB, G0S2, TSHZ2, TM4SF18, ITIH5, EFEMP1, CAV2, CX3CL1, TCEAL7, EGR3, SCN4B, PPL, C16orf89, EBF1, MAOB, ANXA1, MME, ANK2, ABCA6, CXCL2, IRX1, MIR100HG, LMOD1, NDRG2, NFIB, SAMD5, AOC3, NR3C2, LHFP, COL6A6, CITED1, CDO1, BOC, TIMP4, INHBB, GSN

DEG, differentially expressed gene.